|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Song Q, Liu H, Wang J, et al:
Dinner-to-bed time and post-dinner walk: new potential independent
factors in esophageal cancer development. J Cancer Res Clin Oncol.
140:817–821. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong TS, Man OY, Tsang CM, et al: MicroRNA
let-7 suppresses nasopharyngeal carcinoma cells proliferation
through downregulating c-Myc expression. J Cancer Res Clin Oncol.
137:415–422. 2011. View Article : Google Scholar :
|
|
5
|
Wang C, Wang X, Liang H, et al: miR-203
inhibits cell proliferation and migration of lung cancer cells by
targeting PKCalpha. PLoS One. 8:e739852013. View Article : Google Scholar
|
|
6
|
Thulin P, Wei T, Werngren O, et al:
MicroRNA-9 regulates the expression of peroxisome
proliferator-activated receptor delta in human monocytes during the
inflammatory response. Int J Mol Med. 31:1003–1010. 2013.PubMed/NCBI
|
|
7
|
Ratner ES, Tuck D, Richter C, et al:
MicroRNA signatures differentiate uterine cancer tumor subtypes.
Gynecol Oncol. 118:251–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao BS, Liu SG, Wang TY, et al: Screening
of microRNA in patients with esophageal cancer at same tumor node
metastasis stage with different prognoses. Asian Pac J Cancer Prev.
14:139–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kinoshita T, Hanazawa T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion through targeting laminin-332 in head and neck squamous
cell carcinoma. Oncotarget. 3:1386–1400. 2012.PubMed/NCBI
|
|
10
|
Yamamoto N, Kinoshita T, Nohata N, et al:
Tumor suppressive microRNA-218 inhibits cancer cell migration and
invasion by targeting focal adhesion pathways in cervical squamous
cell carcinoma. Int J Oncol. 42:1523–1532. 2013.PubMed/NCBI
|
|
11
|
Tatarano S, Chiyomaru T, Kawakami K, et
al: miR-218 on the genomic loss region of chromosome 4p15.31
functions as a tumor suppressor in bladder cancer. Int J Oncol.
39:13–21. 2011.PubMed/NCBI
|
|
12
|
Uesugi A, Kozaki K, Tsuruta T, et al: The
tumor suppressive microRNA miR-218 targets the mTOR component
Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res.
71:5765–5778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jacobs JJ, Kieboom K, Marino S, DePinho RA
and van Lohuizen M: The oncogene and Polycomb-group gene bmi-1
regulates cell proliferation and senescence through the ink4a
locus. Nature. 397:164–168. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng F, Liao YJ, Cai MY, et al: The
putative tumour suppressor microRNA-124 modulates hepatocellular
carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut.
61:278–289. 2012. View Article : Google Scholar
|
|
15
|
Tu Y, Gao X, Li G, et al: MicroRNA-218
inhibits glioma invasion, migration, proliferation, and cancer
stem-like cell self-renewal by targeting the polycomb group gene
Bmi1. Cancer Res. 73:6046–6055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Z, Li J, Tian L, et al: MiRNA
expression profile reveals a prognostic signature for esophageal
squamous cell carcinoma. Cancer Lett. 350:34–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang X, Lv W, Zhang JH and Lu DL: miR96
functions as a tumor suppressor gene by targeting NUAK1 in
pancreatic cancer. Int J Mol Med. 34:1599–1605. 2014.PubMed/NCBI
|
|
18
|
Wang A, Landen NX, Meisgen F, et al:
MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma
and regulates cell motility and colony formation ability of tumor
cells. PloS One. 9:e1032062014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alajez NM, Lenarduzzi M, Ito E, et al:
MiR-218 suppresses nasopharyngeal cancer progression through
downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res.
71:2381–2391. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tie J, Pan Y, Zhao L, et al: MiR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He X, Dong Y, Wu CW, et al: MicroRNA-218
inhibits cell cycle progression and promotes apoptosis in colon
cancer by downregulating BMI1 polycomb ring finger oncogene. Mol
Med. 18:1491–1498. 2012.PubMed/NCBI
|
|
22
|
van der Lugt NM, Domen J, Linders K, et
al: Posterior transformation, neurological abnormalities, and
severe hematopoietic defects in mice with a targeted deletion of
the bmi-1 proto-oncogene. Genes Dev. 8:757–769. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vrzalikova K, Skarda J, Ehrmann J, et al:
Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients:
a tissue microarray study. J Cancer Res Clin Oncol. 134:1037–1042.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gavrilescu MM, Todosi AM, Anitei MG, Filip
B and Scripcariu V: Expression of bmi-1 protein in cervical, breast
and ovarian cancer. Rev Med Chir Soc Med Nat Iasi. 116:1112–1117.
2012.
|
|
25
|
Wu Z, Wang Q, Wang L, et al: Combined
aberrant expression of Bmi1 and EZH2 is predictive of poor
prognosis in glioma patients. J Neurol Sci. 335:191–196. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hamada S, Satoh K, Masamune A and
Shimosegawa T: Regulators of epithelial mesenchymal transition in
pancreatic cancer. Front Physiol. 3:2542012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Paranjape AN, Balaji SA, Mandal T, Krushik
EV, Nagaraj P, Mukherjee G and Rangarajan A: Bmi1 regulates
self-renewal and epithelial to mesenchymal transition in breast
cancer cells through Nanog. BMC Cancer. 14:7852014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He Q, Liu Z, Zhao T, Zhao L, Zhou X and
Wang A: Bmi1 drives stem-like properties and is associated with
migration, invasion, and poor prognosis in tongue squamous cell
carcinoma. Int J Biol Sci. 11:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Lian G, Zhang Q, Zeng L, Qian C,
Chen S and Huang K: Overexpression of Bmi-1 induces the malignant
transformation of gastric epithelial cells in vitro. Oncol Res.
21:33–41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xin T, Zhang FB, Sui GJ and Jin XM: Bmi-1
siRNA inhibited ovarian cancer cell line growth and decreased
telomerase activity. Br J Biomed Sci. 69:62–66. 2012.PubMed/NCBI
|
|
31
|
Peruzzi P, Bronisz A, Nowicki MO, et al:
MicroRNA-128 coordinately targets Polycomb Repressor Complexes in
glioma stem cells. Neuro Oncol. 15:1212–1224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo S, Xu X, Tang Y, et al: miR-15a
inhibits cell proliferation and epithelial to mesenchymal
transition in pancreatic ductal adenocarcinoma by down-regulating
Bmi-1 expression. Cancer Lett. 344:40–46. 2014. View Article : Google Scholar
|
|
33
|
Okumura T, Shimada Y, Moriyama M, et al:
MicroRNA-203 inhibits the progression of esophageal squamous cell
carcinoma with restored epithelial tissue architecture in vivo. Int
J Oncol. 44:1923–1932. 2014.PubMed/NCBI
|
|
34
|
Kogo R, How C, Chaudary N, Bruce J, Shi W,
Hill RP, Zahedi P, Yip KW and Liu FF: The microRNA-218~Survivin
axis regulates migration, invasion, and lymph node metastasis in
cervical cancer. Oncotarget. 6:1090–1100. 2015.
|
|
35
|
Sui C, Xu F, Shen W, Geng L, Xie F, Dai B,
Lu J, Zhang M and Yang J: Overexpression of miR-218 inhibits
hepatocellular carcinoma cell growth through RET. Tumour Biol.
36:1511–1518. 2015. View Article : Google Scholar
|
|
36
|
Nishikawa R, Goto Y, Sakamoto S, Chiyomaru
T, Enokida H, Kojima S, Kinoshita T, Yamamoto N, Nakagawa M, Naya
Y, et al: Tumor-suppressive microRNA-218 inhibits cancer cell
migration and invasion via targeting of LASP1 in prostate cancer.
Cancer Sci. 105:802–811. 2014. View Article : Google Scholar : PubMed/NCBI
|
